Non-Invasive, Dual-Targeted BBB Delivery Solution for Non-Brain Penetrant CNS Therapeutic Agents

15 December 2020 14:30 - 15:05

Learn from Award Winning Biotech how an Innovative Nanovesicle Platform for Non-Invasive, Dual-Targeted Delivery of Non-BBB Penetrants (Ab, siRNA, biologic, sm. mol.) is used to develop Transformative Nanomedicines Pipeline for Unmet CNS Medical Needs (ALS, PD, GBM, AD, Pain, Neuro-HIV)

Susan Rosenbaum, Founder, Chairman, CEO , Lauren Sciences